Multiple sclerosis

Related records

Broader conditions (16)

• Autoimmune disease
• Autoimmune disorder of central nervous system
• Autoimmune disorder of the nervous system
• Brain disorder
• Central nervous system disorder
• CNS demyelinating autoimmune disease
• Demyelinating disease
• Demyelinating disease of central nervous system
• Disease
• Disease by body system or component
• Disease by developmental or physiological process
• Disorder of development or morphogenesis
• Human disease
• Immune system disorder
• Nervous system disorder
• Neurodegenerative disease

Narrower conditions (7)

• Chronic progressive multiple sclerosis
• Marburg acute multiple sclerosis
• Pediatric multiple sclerosis
• Primary progressive multiple sclerosis
• Progressive relapsing multiple sclerosis
• Relapsing-remitting multiple sclerosis
• Secondary progressive multiple sclerosis

Trials (3,136)

• " Treating MS Patients With Lower Extremity Spasticity Using Dysport"
• "Balance, Gait, and Motion Analysis in Multiple Sclerosis"
• "Evaluation of Usability and Safety of the Self-balancing Walking System Atalante in Patients With Multiple Sclerosis"
• "HB-adMSCs for the Treatment of Patients With Multiple Sclerosis"
• "Outwalk MS" - Benefits of Outdoor Walking in Multiple Sclerosis
• "Selfie" Videos: A Novel, Patient-centered, Comprehensive Approach to Measuring Function in MS
• [11C]-PBR28 Positron Emission Tomography Study to Evaluate the Effect of ABT 555 in Subjects With Relapsing Forms of Multiple Sclerosis
• [18F]PBR111 and Microglial Activation in Multiple Sclerosis
• 12-week Safety Evaluation of Oral CS-0777 in Multiple Sclerosis Patients
• 12-week Study to Evaluate RebiSmart™ Suitability for Self Injection in Relapsing Multiple Sclerosis.
• 3 Meter Backwards Walk Test and Multiple Sclerosis
• 31P-MRS Imaging to Assess the Effects of CNM-Au8 on Impaired Neuronal Redox State in Multiple Sclerosis.
• 3D FLAIR Versus Coronal T2-WI MRI in Detecting Optic Neuritis (FLACON)
• 3D OPTIMIZED WMN MPRAGE Increased Detection of Focal Spinal Cord Lesion in Multiple Sclerosis (WHINUME)
• 3D Phase Sensitive Inversion Recuperation MRI to Detect and Characterize Multiple Sclerosis Spinal Cord Lesions
• 5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis
• A "negative"dendritic Cell-based Vaccine for the Treatment of Multiple Sclerosis: a First-in-human Clinical Trial
• A 12 -Month, Open-label, Multi-center Study to Explore the Health Outcomes of FTY720
• A 12 Week Randomized Open Label Parallel Group Multicenter Study to Evaluate Bioequivalence of 20 mg Subcutaneous Ofatumumab Injected by Pre-filled Syringe or Autoinjector in Adult RMS Patients
• A 3-year Multi-center Study to Describe Changes of OCT Parameters Under Treatment With Gilenya®

Approved drugs (35)

• Alemtuzumab
• Baclofen
• Cladribine
• Corticotropin
• Daclizumab
• Dalfampridine
• Dantrolene sodium
• Dexamethasone
• Dimethyl fumarate
• Diroximel fumarate
• Fingolimod hydrochloride
• Fingolimod lauryl sulfate
• Glatiramer acetate
• Interferon beta-1A
• Interferon beta-1B
• Lincomycin
• Methylprednisolone
• Methylprednisolone sodium succinate
• Mitoxantrone hydrochloride
• Monomethyl fumarate

Drugs in development (200)

• Abatacept Phase 2
• Acetaminophen Phase 3
• Acetazolamide Phase 2
• Acetylcysteine Phase 2
• Acyclovir sodium Phase 3
• Alfuzosin Phase 2
• Amantadine Phase 3
• Amantadine hydrochloride Phase 3
• Amifampridine Phase 3
• Amiselimod hydrochloride Phase 2
• Anakinra Phase 1
• Arbaclofen placarbil Phase 3
• Armodafinil Phase 2
• ASP-4058 Phase 1
• Aspirin Phase 3
• Atacicept Phase 2
• Atorvastatin Phase 2
• Azficel-T Phase 3
• Azithromycin Phase 2
• Belimumab Phase 2

Other linked drugs (7)

• Aspartic acid
• Gadolinium
• Gadoteridol
• Incobotulinumtoxina
• Leflunomide
• Sodium phosphate, dibasic, anhydrous
• TOL-101